AU2003290563A1 - Leptin-related peptides - Google Patents

Leptin-related peptides

Info

Publication number: AU2003290563A1
Authority: AU; Australia
Prior art keywords: leptin; related peptides; peptides
Prior art date: 2002-10-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003290563A

Other versions

AU2003290563A8 (en

Inventor

Patricia Grasso

Daniel W. Lee

Matthew C. Leinung

Maria Rozhavskaya-Arena

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

CLF Medical Technology Acceleration Program Inc

Original Assignee

CLF Medical Technology Acceleration Program Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-31

Filing date

2003-10-31

Publication date

2004-05-25

2003-10-31 Application filed by CLF Medical Technology Acceleration Program Inc filed Critical CLF Medical Technology Acceleration Program Inc

2004-05-25 Publication of AU2003290563A1 publication Critical patent/AU2003290563A1/en

2004-05-25 Publication of AU2003290563A8 publication Critical patent/AU2003290563A8/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Child & Adolescent Psychology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Endocrinology (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Obesity (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2003290563A 2002-10-31 2003-10-31 Leptin-related peptides Abandoned AU2003290563A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US42272302P	2002-10-31	2002-10-31
US60/422,723		2002-10-31
PCT/US2003/034820 WO2004039832A2 (en)	2002-10-31	2003-10-31	Leptin-related peptides

Publications (2)

Publication Number	Publication Date
AU2003290563A1 true AU2003290563A1 (en)	2004-05-25
AU2003290563A8 AU2003290563A8 (en)	2004-05-25

Family

ID=32230382

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003290563A Abandoned AU2003290563A1 (en)	2002-10-31	2003-10-31	Leptin-related peptides

Country Status (2)

Country	Link
AU (1)	AU2003290563A1 (en)
WO (1)	WO2004039832A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2849552A1 (en)	2004-02-11	2005-08-25	Amylin Pharmaceuticals, Llc	Hybrid polypeptides with selectable properties
US8076288B2 (en)	2004-02-11	2011-12-13	Amylin Pharmaceuticals, Inc.	Hybrid polypeptides having glucose lowering activity
NZ561361A (en)	2005-02-11	2010-02-26	Amylin Pharmaceuticals Inc	GIP hybrid polypeptides with at least two hormonal activities
US8263545B2 (en)	2005-02-11	2012-09-11	Amylin Pharmaceuticals, Inc.	GIP analog and hybrid polypeptides with selectable properties
BRPI0614649A2 (en)	2005-08-11	2011-04-12	Amylin Pharmaceuticals Inc	hybrid polypeptides with selectable properties
CA2617649A1 (en)	2005-08-11	2007-02-22	Amylin Pharmaceuticals, Inc.	Hybrid polypeptides with selectable properties
US8497240B2 (en)	2006-08-17	2013-07-30	Amylin Pharmaceuticals, Llc	DPP-IV resistant GIP hybrid polypeptides with selectable properties
GB2451858A (en) *	2007-08-15	2009-02-18	Sergiy Konovchuk	Methods of reducing body fat and treating obesity
WO2009108340A2 (en)	2008-02-27	2009-09-03	Temple University - Of The Commonwealth System Of Higher Education	Leptin agonist and methods of use
EP2416797A4 (en)	2009-04-10	2013-04-24	Amylin Pharmaceuticals Llc	Amylin agonist compounds for estrogen-deficient mammals
EP2482833A4 (en) *	2009-07-01	2013-05-01	Univ Temple	Leptin agonist and methods of use
CA2813038C (en)	2010-09-28	2021-12-28	Amylin Pharmaceuticals, Llc	Highly soluble leptins
WO2013009539A1 (en)	2011-07-08	2013-01-17	Amylin Pharmaceuticals, Inc.	Engineered polypeptides having enhanced duration of action and reduced immunogenicity
CN104822374A (en)	2012-09-27	2015-08-05	儿童医学中心公司	Compounds for treatment of obesity and methods of use thereof
PL3074033T3 (en)	2013-11-26	2019-08-30	The Children's Medical Center Corporation	Compounds for the treatment of obesity and methods of use thereof
US20170209408A1 (en)	2014-04-03	2017-07-27	The Children's Medical Center Corporation	Hsp90 inhibitors for the treatment of obesity and methods of use thereof
RS64850B1 (en)	2016-09-12	2023-12-29	Amryt Pharmaceuticals Inc	Methods of detecting anti-leptin neutralizing antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2623458A1 (en) *	1999-05-17	2000-11-23	Conjuchem Biotechnologies Inc.	Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
AU2002256624B2 (en) *	2001-02-19	2007-12-06	Merck Patent Gmbh	Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity

2003
- 2003-10-31 WO PCT/US2003/034820 patent/WO2004039832A2/en not_active Application Discontinuation
- 2003-10-31 AU AU2003290563A patent/AU2003290563A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2003290563A8 (en)	2004-05-25
WO2004039832A3 (en)	2006-10-05
WO2004039832A2 (en)	2004-05-13

Publication	Publication Date	Title
AU2002335152A1 (en)	2003-09-04	Robot-phone
AU2003290563A1 (en)	2004-05-25	Leptin-related peptides
AU2003228863A1 (en)	2003-11-17	Immunogenic peptides
AU2003246644A1 (en)	2004-01-23	Secreted peptides
AU2003202694A1 (en)	2003-09-02	Torero protein
AU2003302330A1 (en)	2004-07-22	Antimicrobial peptides
AU2003270055A1 (en)	2004-03-29	Neurotransmission-associated proteins
AU2003278718A1 (en)	2004-03-11	Stars-a muscle-specification-binding protein
AU2003220217A1 (en)	2003-09-29	Identifying peptide modifications
AU2002341221A1 (en)	2004-04-19	Honey-brandy
AU2003300785A1 (en)	2004-06-03	Carbohydrate-associated proteins
AU2002344387A1 (en)	2003-12-22	Multifunction-pillow
AU2003211501A1 (en)	2003-09-02	Peptides
AU2003295760A1 (en)	2004-06-18	Organelle-associated proteins
AU2003236908A1 (en)	2004-01-06	Proteins
AU2003254865A1 (en)	2004-02-25	Akt2-BINDING PROTEIN
AUPS130102A0 (en)	2002-05-09	Novel peptides
AU2003211532A1 (en)	2003-09-09	Novel polypeptide
AU2002328853A1 (en)	2003-01-21	Carcinoma-related peptides
GB0219980D0 (en)	2002-10-09	Peptides
AU2002100957A4 (en)	2003-06-12	Sluggit
AU2002100510A4 (en)	2002-11-21	Bottlenecker
AU2002100160A4 (en)	2002-04-11	Oxidirator
AU2002100280A4 (en)	2002-05-09	Proshoe
AU2002100468A4 (en)	2002-11-14	Flexi-edger

Legal Events

Date	Code	Title	Description
2005-07-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase